Alberto Bongiovanni

16PUBLICATIONS
48CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMolecular targetsPainSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 24, 2025
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic Opportunities.

Alberto Bongiovanni, Pierfranco Conte, Vincenza Conteduca

|Apr 13, 2024
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort.

Francesco Panzuto, Elisa Andrini, Giuseppe Lamberti

|May 13, 2023
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET).

Giuseppe Lamberti, Natalie Prinzi, Alberto Bongiovanni

|Feb 25, 2023
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin.

Valentina Fausti, Alessandro De Vita, Silvia Vanni

|Dec 23, 2022
177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials.

Alberto Bongiovanni, Silvia Nicolini, Toni Ibrahim

|Jul 09, 2022
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data Analysis.

Nicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca

Pageof 3

Frequent Collaborators

10 joint publications

Toni Ibrahim

7 joint publications

Alessandro De Vita

4 joint publications

Flavia Foca

3 joint publications

Nicoletta Ranallo